Molecular cloning and expression of a variant form of hippostasin/KLKII in prostate

被引:23
作者
Nakamura, T
Mitsui, S
Okui, A
Miki, T
Yamaguchi, N
机构
[1] Kyoto Prefectural Univ Med, Dept Cell Biol, Res Inst Geriatr, Kamigyo Ku, Kyoto 6028566, Japan
[2] Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, Kyoto 6028566, Japan
[3] Fuso Pharmaceut Ind Ltd, Dept Biol Sci Res, R&D Ctr, Joto Ku, Osaka, Japan
关键词
alternative splicing; kallikrein; serine protease;
D O I
10.1002/pros.10191
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Hippostasin is a kallikrein-like serine protease, which has two alternatively spliced isoforms, brain-type and prostate-type. We previously reported alternative expression of hippostasin in prostate cancer cell lines. METHODS. We studied the expression of a variant-form hippostasin (isoform 3) mRNA by RT-PCR. Localization of the isoform 3 protein was examined by immunohistochemistry. The enzymatic activity of the recombinant protein was measured with synthetic substrates. RESULTS. A novel isoform of hippostasin contains 25 additional amino acids in the catalytic triad of brain-type hippostasin. Its mRNA was expressed in normal prostate tissue, BPH, and prostate cancer cell lines. The protein was localized in the prostate secretory epithelium. The enzyme activity was similar to that of brain-type hippostasin, which has kallikrein-like activity. CONCLUSIONS. In this study, we have identified a third isoform of hippostasin, which was designated variant-form (isoform 3). Hippostasin isoform 3 may play a role in the prostate, including reproductive and/or turnorigenic functions. Prostate 54: 299-305, 2003. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 16 条
[1]  
CHAN R, 2001, ANTICANCER RES, V21, P3147
[2]   Using the receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure [J].
Cheung, R ;
Altschuler, MD ;
D'Amico, AV ;
Malkowicz, SB ;
Wein, AJ ;
Whittington, R .
UROLOGY, 2001, 58 (03) :400-405
[3]  
Diamandis EP, 2000, CLIN CHEM, V46, P1855
[4]  
Diamandis EP, 2002, CANCER RES, V62, P295
[5]   Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy - The 15-year Johns Hopkins experience [J].
Han, M ;
Partin, AW ;
Pound, CR ;
Epstein, JI ;
Walsh, PC .
UROLOGIC CLINICS OF NORTH AMERICA, 2001, 28 (03) :555-+
[6]  
Heuzé N, 1999, CANCER RES, V59, P2820
[7]   Crystal structure of neuropsin, a hippocampal protease involved in kindling epileptogenesis [J].
Kishi, A ;
Kato, M ;
Shimizu, T ;
Kato, K ;
Matsumoto, K ;
Yoshida, S ;
Shiosaka, S ;
Hakoshima, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (07) :4220-4224
[8]   Identification of three new alternate human kallikrein 2 transcripts: Evidence of long transcript and alternative splicing [J].
Liu, XF ;
Essand, M ;
Vasmatzis, G ;
Lee, B ;
Pastan, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (03) :833-839
[9]   Clinical usefulness of free PSA in early detection of prostate cancer [J].
Luboldt, HJ ;
Swoboda, A ;
Börgermann, C ;
Fornara, P ;
Rübben, H .
ONKOLOGIE, 2001, 24 (01) :33-37
[10]  
Magklara A, 2001, CLIN CANCER RES, V7, P806